MedAdvisor and HPS collaborate to develop an Integrated Medication Management solution for use in Hospitals

MedAdvisor and HPS collaborate to develop an Integrated Medication Management solution for use in Hospitals

For Immediate Release

 

Melbourne - MedAdvisor Limited, Australia’s leading digital medication management company, is pleased to announce it has signed an initial agreement for up to 12 months with HPS, Australia’s largest provider of outsourced pharmacy services to private hospitals. The Agreement with HPS, a subsidiary of EBOS Group Limited, follows EBOS’ strategic investment in the Company announced on 23rd of October 2017 and the Memorandum of Understanding signed between MedAdvisor and HPS at that time (‘MoU’).

 

Since the MoU was signed, the parties have been working collaboratively in partnership with Zest, a business of EBOS Group Limited, to develop an integrated medication management solution for use in hospitals. The joint solution will give MedAdvisor patients full control and oversight, to expressly authorise and permit hospital pharmacists to electronically request and retrieve the patient’s own medication history from MedAdvisor at the time of admission. When integrated with ClinPod® (HPS’ medication management clinical information system) and coupled with hospital pharmacist workflows, the joint solution is expected to help with continuity of care, improve information flow and reduce the risk of medication misadventure for patients in hospital.

 

Furthermore, the offering will enable the patient to authorise the timely reporting of their current medications at the time of discharge to their preferred GP and pharmacy, thus improving the transition of care back into the community setting.

 

For MedAdvisor, a successful pilot could extend the patient acquisition and engagement channels beyond community pharmacies and GP to include hospitals and should improve the hospital admission process for both patients and the hospital. Additionally, the solution has the potential to build further value into the existing relationships with community pharmacies and GPs through timely and effective notifications regarding their patients.

 

Robert Read, CEO of MedAdvisor commented, “We are delighted to be working with HPS to develop a technical solution for hospital pharmacies that will simplify the admission process for patients and potentially make hospital pharmacies more productive and efficient. We believe an integrated solution that fully empowers the patient, whilst making the admission process simpler for patients and more efficient for the hospital represents a win/win. Ensuring better continuity of care for patients back into the community setting after a hospital episode, as well as finding ways to encourage behaviours that drive medication adherence is aligned with MedAdvisor’s purpose and represents a key goal for the overall health system.”

 

Jeremy Stones, CEO of HPS said, “Working with MedAdvisor to offer an integrated medication management solution to patients helps us to deliver on an important strategic priority that seeks to optimise safety and quality throughout the medication management continuum. By building better connectivity for the patient’s themselves, beyond the hospital context, we believe HPS can better support patients when managing their transitions of care.”

 

---ENDS---

 

For more information

 

Jennifer Duraisingam Corporate Communications Manager Tel: +61 438 330 545 jenniferd@medadvisor.com.au

 

About MedAdvisor

MedAdvisor is a world class digital medication management platform focused on addressing the gap and burden of medication adherence. Founded with a desire to simplify medication management, the highly automated and intuitive Australian software system connects patients to their community pharmacy, providing them with real time access to their personal medication records. Available free on mobile and internet devices, the platform also incorporates a variety of valuable and convenient features including reminders and preordering of medications, which together improves adherence to chronic medications by approximately 20%.

 Since launching in 2013, MedAdvisor has welcomed over one million users through its connections with ~50% of pharmacies and a network of over a thousand GPs across Australia.

Follow us on:

    Twitter:  @MedAdvisor_AU  

    LinkedIn:  MedAdvisor International Pty Ltd  

Facebook: MedAdvisor

 About EBOS

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.

    About HPS

HPS and its network of HPS Approved Pharmacies is one of Australia’s leading suppliers of pharmacy services to health facilities, including private hospitals, public hospitals, cancer centres and correctional facilities. Operating in all states and territories across Australia, HPS services clients nationally, including state government departments and private health facilities. HPS’ network of almost 50 pharmacies delivers services to 7,000 private and public hospital beds, and over 10,000 correctional patients per annum. HPS is 100% owned by EBOS Group.

    About Zest

With three separate business divisions, Zest offers a diverse range of solutions to the healthcare market in Australia. These include Zest Healthcare Communications, which produces educational materials, web sites, disease awareness and professional development programs, Zest Health Strategies, which works to align public policy and strategy with patient needs and healthcare services, and Zest Patient Support, which works to inform, reassure and support patients. Each business is made up of professionals unmatched in the market, working to best practice principles to deliver outstanding results.